BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6348940)

  • 1. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG; Müller P; Seitz HK; Simon B
    Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
    Müller P; Seitz HK; Simon B; Dammann HG
    Arzneimittelforschung; 1983; 33(12):1685-6. PubMed ID: 6686775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [4 weeks' administration of omeprazole: effect on acid behavior and basal hormone levels].
    Müller P; Seitz HK; Simon B; Dammann HG; Feurle G; Huefner M; Lichtwald K; Schmidt-Gayk H
    Z Gastroenterol; 1984 May; 22(5):236-40. PubMed ID: 6741200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of omeprazole on gastric acid secretion in man.
    Olbe L; Lind T; Cederberg C; Ekenved G
    Scand J Gastroenterol Suppl; 1986; 118():105-7. PubMed ID: 3460164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
    Howden CW; Forrest JA; Reid JL
    Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of gastric acid secretion by 10 mg and 30 mg omeprazole once daily.
    Nielsen AM; Stenderup J; Wandall JH; Bonnevie O
    Scand J Gastroenterol; 1985 Dec; 20(10):1236-8. PubMed ID: 3912960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
    Wilson JA; Boyd EJ; Wormsley KG
    Dig Dis Sci; 1984 Sep; 29(9):797-801. PubMed ID: 6432499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
    Olbe L; Lind T; Carlsson E; Cederberg C; Helander H; Wallmark B
    Schweiz Med Wochenschr; 1984 May; 114(20):683-5. PubMed ID: 6740286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
    Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
    Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
    Lind T; Cederberg C; Ekenved G; Haglund U; Olbe L
    Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo.
    Larsson H; Mattson H; Sundell G; Carlsson E
    Scand J Gastroenterol Suppl; 1985; 108():23-35. PubMed ID: 3858975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.
    Festen HP; Tuynman HA; Défize J; Pals G; Frants RR; Straub JP; Meuwissen SG
    Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid inhibitory characteristics of omeprazole in man.
    Cederberg C; Ekenved G; Lind T; Olbe L
    Scand J Gastroenterol Suppl; 1985; 108():105-12. PubMed ID: 3858972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.
    Thompson JN; Barr JA; Collier N; Spencer J; Bush A; Cope L; Gribble RJ; Baron JH
    Gut; 1985 Oct; 26(10):1018-24. PubMed ID: 3932137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human gastric acid secretion following repeated doses of AG-1749.
    Müller P; Dammann HG; Leucht U; Simon B
    Aliment Pharmacol Ther; 1989 Apr; 3(2):193-8. PubMed ID: 2491469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
    Dammann HG; Burkhardt F
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects.
    Bruley des Varannes S; Gharib H; Bicheler V; Bost R; Bonaz B; Stanescu L; Delchier JC; Bonnot-Marlier S
    Aliment Pharmacol Ther; 2004 Oct; 20(8):899-907. PubMed ID: 15479362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
    Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
    Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.